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COMMENTARY: Scholarly Essays, Critical Analyses, and Policy Papers

Ethical Dilemmas in Publishing a Journal of Public Health Practice
Harry Perlstadt, Ph.D, M.P.H. Michigan State University

Publication is a gateway where an ethics checkpoint can be established. Institutional
Review Boards (IRB) and Ethics Review Committees at academic institutions and
medical facilities grant prior approval for and then monitor biomedical and behavioral
research involving human subjects, primarily to minimize or avoid ethical problems.
The end product of research is generally the dissemination of findings in a professional
journal. Journals, then, can provide additional ethical safeguards after the research has
been completed (Creinin and Shields, 2005). Editors and editorial boards of most
scientific and professional journals have been willing to assume the role of voluntary,
that is, non-governmental gatekeeper and enforcer of federal guidelines for the
protection of human subjects.

While publishing both research and practice findings is essential to improving the health
and well-being of individuals and society, human subjects participating in both health and
behavioral research and public health practice have a right to privacy that should not be breached.
Public health authorities have a long history of respecting the confidentiality of public health
records, data, and other information. The majority of states as well as the federal government have
laws that govern the use of, and serve to protect, identifiable information collected by public
health authorities (MMWR, 2003) .
The International Committee of Medical Journal Editors Uniform Requirements for
Manuscripts states that:
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,or hospital numbers, should not
be published in written descriptions, photographs, and pedigrees unless the information is
essential for scientific purposes and the patient (or parent or guardian) gives written
informed consent for publication. Informed consent for this purpose requires that a patient
who is identifiable be shown the manuscript to be published. Identifying details should be
omitted if they are not essential. Complete anonymity is difficult to achieve, however, and
informed consent should be obtained if there is any doubt (ICMJE, 2006).
Many journals perform this ethics check by requiring authors to either affirm or submit
documentation that their project received prior review and approval from an Institutional Review
Board or Ethics Review Committee. This ethics check, however, varies greatly from journal to
journal and by research area. While over 500 journals have adopted the Uniform Requirements,
Amdur and Biddle (1997) found that less than half (47%) required IRB approval for studies
involving human subjects as a prerequisite for publication. In addition, the journal Pediatrics
reported that 97 percent of randomized, clinical trials claimed IRB approval, compared with 70
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percent of prospective cohort studies, 37 percent of retrospective cohort studies, but only 9
percent of large dataset analyses (Bauchner, 2002).
These findings reflect the distinction between research and practice. The Belmont Report,
written by the National Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research (National Commission, 1979) identified the three ethical principles of respect
for persons, beneficence and justice, and defined the boundary between biomedical and behavioral
research and the accepted and routine practice of medicine. Practice was defined as interventions
designed solely to improve the well being of an individual patient or client while research was to
test a hypothesis and contribute to generalizable knowledge. The Belmont Report held that if any
element of research is present in an activity, that activity should undergo review for the protection
of human subjects. These recommendations were incorporated into federal regulations known as
the Common Rule (45 CFR 46).
It is quite clear that most existing medical and research codes fail to take public health into
account (Kass, 2001). The National Commission did not have any members directly involved in
public health, and neither the Belmont Report (
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1978b) two commissioned background papers mention public health or epidemiology. This placed
public health in a sort of ethical limbo. Two issues need to be addressed: first, how to distinguish
public health research, which requires IRB approval, from public health practice which does not
always require IRB approval, and second, how to reconcile regulations designed to protect
individuals with the need to protect communities and populations.
DISTINGUISHING PUBLIC HEALTH RESEARCH AND PRACTICE
Defining the boundary between public health research and practice is problematic (Burris,
Buehler and Lazarini, 2003). In his background paper for the Belmont Report, Levine (1978a)
briefly explored the boundaries between the research activities and professional practices of social
scientists. Epidemiology is not mentioned, and Levine (1978a:23), almost as an afterthought,
wonders whether it is to society that we ought to offer the opportunity to give informed consent.
State authorization is surely the equivalent of societal informed consent, and society has created,
tasked and financed public health research and practice.
Public health practice is authorized and governed primarily by state rather than federal
laws that require health departments and agencies to systematically collect data for surveillance,
disease control and prevention, and program development and evaluation (MacQueen and
Buehler, 2004). Since these practice-based activities are also carried out by researchers, it may be
difficult to determine which public health activities constitute research and which represent
public health practice, or when practice activities evolve into research activities.
In January 1999, the Director, Division of Human Subject Protections, Office for
Protection from Research Risks (OPRR) issued a memo (Puglisi, 1999) requiring each institution
engaged in human subjects research to provide OPRR with a satisfactory Assurance to comply
with the federal regulations at 45 CFR 46.101(b). In response, the Centers for Disease Control and
Prevention prepared Defining Public Health Research and Public Health Non-Research (Speers,
1999). This document stated that the federal regulations or Common Rule (45 CFR 46) did not
directly address many public health activities and did not recognize the statutory authority of state
and local health departments to conduct public health activities using methods similar to those
used by researchers. This meant that the human subject protections applicable for activities
occurring at the boundary between public health research and non-research (practice) were not
readily interpretable from the regulations.
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The document claimed that CDC could decide what research was and whether the Federal
regulations were applicable, although final determination ultimately rested with the Office for
Protection from Research Risks (OPRR). The CDC wanted to provide guidance to state and local
health departments and other institutions that conduct research with CDC staff or were recipients
of CDC funds. But it did not describe how this collaboration would be achieved or how the ethical
guidelines would be adopted or even recognized by the IRBs of various CDC partners including
universities and health/hospital systems.
The CDC document (Speers, 1999) asserted that what distinguished research from nonresearch (practice) was the primary intent or, in the words of the regulations, the design of the
activity. Levine (1978a) first identified the importance of intent when he recognized that clinical
research involved a set of complex activities some of which may be administered for therapeutic
purposes, while other procedures were undertaken solely to answer a scientific question. Weijer
(2001) explained that therapeutic procedures, that is medical practices, are justified by their
potential to benefit the subject, while non-therapeutic procedures, that is research, are justified by
their potential to generate knowledge. He agreed that the difference in intent is what is morally
relevant.
But the CDC (Speers, 1999) then goes on to assert that the primary intent of non-research
(practice) in public health is to protect the health of the population through such activities as
disease surveillance, prevention, or control. Non-research activities systematically gather
information designed to benefit to benefit a specific community, although occasionally they may
provide unintended generalizable benefits to others by, for example, preventing the spread of a
disease to other vulnerable populations (MMWR, 2003). Knowledge generated by such nonresearch activities does not extend beyond the scope of the activity.
Furthermore, CDC argued that even if a non-research project may produce generalizable
knowledge after the project is completed, the initial non-research classification remains in force.
But if subsequent analysis is undertaken that involves gathering or using identifiable private
information to generate or contribute to generalizable knowledge, then the analysis constitutes
human subjects research and requires IRB review. Finally, if a project includes multiple
components and at least one of those components is designed to generate generalizable
knowledge, then the entire project is classified as research unless the components are separable.
The CDC (Speers, 1999) also stated that publication or dissemination of findings do not
necessarily differentiate research from non-research. From an ethics perspective, information
collected through public health practice falls under the HIPAA Privacy Rule (Standards for
Privacy of Individually Identifiable Health Information) which expressly permits certain
information to be shared for specified public health purposes. For example, some information may
be disclosed without individual authorization to a public health authority legally authorized to
collect or receive the information for the purpose of preventing or controlling disease, injury, or
disability [45 CFR § 164.512(b)]. Further, the Privacy Rule permits covered entities to make
disclosures that are legally required for public health purposes (MMWR, 2003). This differs
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publication Protecting Data Privacy in Health Services Research, which suggested that if the
intent or possible intent of the investigator is publication, then the project represents research and
IRB approval is necessary.
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Table 1: CDC Distinctions between Research and Practice (Non-Research)
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(ref. 45 CFR 46)
To generate new or generalizable
knowledge
(information that can be applied in other
settings)
Scientific principles and methods used.
Hypothesis testing/generating
Knowledge is generalizable

Practice (Non-Research)
May use scientific methods to
identify and control a health
problem with benefits for the study
participants or their communities.

Surveillance
Projects

Scope of data is broad
Analytic analyses
Hypothesis testing
Subsequent studies using cases

Regular, ongoing collection and
analyses to measure occurrence of
health problem (disease registry)
Scope of data is health condition
or disease, demographics, and
known risk factors
Invokes public health mechanisms
to prevent or control disease or
injury

Emergency
Response

Samples stored for future use
Additional analyses performed beyond
immediate problem
Investigational drugs tested

Solves an immediate health
problem
No testing of methods or
interventions

Program
Evaluation

Test an intervention
Systematic comparison of standard and
nonstandard interventions

Assess success of established
intervention
Evaluation information used for
feedback into program
(management)

Definition

Primary Intent

Methodology

To benefit study participants or the
communities from which they
come
Scientific principles and methods
may be used.
Hypothesis testing/generating
Knowledge may be generalizable

Examples

Defining Public Health Research and Public Health Non-Research (Speers, 1999)
contained a table that compared research and practice (or non-research) in terms of definition,
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primary intent, and methodology, as well as providing examples of each for surveillance,
emergency response and program evaluation. As already mentioned, a key difference is in intent
and not in methods used. The main distinction appears to be that research involves additional data
collection using cases (surveillance) or investigational drug testing (emergency response) or
systematic comparisons of standard and non standard interventions (program evaluation) that goes
beyond the regular, routine collection and analyses of data related to known risk factors or the
immediate health problem or program under study.
PROTECTING COMMUNITIES AND POPULATIONS
Four basic principles—autonomy, dignity, integrity, and vulnerability—are offered as a
simple, accessible, and culturally neutral approach to thinking about ethical issues in health care
(Gillon, 1994). But Levine (1982) asked whether such principles are universal valid standards or if
some degree of cultural relativism should be accepted, permitting each culture to decide how it
should show respect for its own members. Weijer (1999) concluded that the only way to take
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from those granted to individual community members.
Weijer and Miller (2004) argued that people generally identify themselves as members of
one or more communities that help form their values and self-understanding. Furthermore, many
communities possess the authority to make binding decisions on behalf of individual members and
can legitimately curtail individual liberty and free will in certain situations. They also recognized
that the primacy of the individual versus the community varies from one community and culture to
another. In particular, individual rights and liberties are held in high esteem in western liberal
nations, but that is not the case in many non-Western nations and in certain groups such as Native
American communities.
In a discussion of ethics and public health, Callahan and Jennings (2002) noted the tension
between the orientation towards individual liberties and autonomy found in the bioethics literature,
regulations, and guidelines on the one hand, and the interests of public health to limit the freedom
of the individual for the sake of (a) his or her own greater good or best interests or (b) the common
good or public interest. They asked whether the bioethical research model focused on individual
informed consent and tightly regulated studies of human subjects at risk of exploitation is an
appropriate model for public health research that may either pose no medical or other risks to the
individual or make consent impractical to gain in research encompassing large communities.
The Belmont Report does not mention the word community at all, and the Common Rule
(45 CFR 46) does not focus on communities per se although it is highly concerned with
vulnerable groups—the mentally ill, children, etc. (Levine, 1988, Weijer, Goldsand and
Emanuel, 1999). Levine (1978a:24), however, mentioned that the community, of which the
subject is a member, is also put at risk as the social scientist uses the information in his
publications or as the basis of his consultative opinion leading to formation of public policy.
Note that public health is conspicuous by its absence or is lumped in with the social sciences.
On the other hand, The International Guidelines for Ethical Review of Epidemiological Studies
(CIOMS, 1991) attempted to apply general ethical principles at the community or population level,
that is, how one community related to another, and how a community treated each of its members
and members of other groups with different cultural values. Specifically the
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Guidelines stated that investigators must respect the ethical standards of their own countries and

the cultural expectations of the societies in which epidemiological studies are undertaken.
The Guidelines then recommend that when individual informed consent cannot be
obtained, community agreement may be sought from a community representative and, if the
study is objectionable to the community, individual informed consent may not be sufficient to
render a study ethical. Whenever possible, investigators should not expose groups to harm,
including the harm of disruption of social mores. Where findings could be applied in public
health measures to improve community health, they should be communicated to the health
authorities and be publicized in the community by whatever suitable means are available.
The Guidelines warned epidemiologists against bringing disadvantage to communities or
transgressing their values. Although cultural values and social mores must be respected, the
Guidelines noted that the purpose of an epidemiological study may be to stimulate change in
certain customs or conventional behaviors that would hopefully improve the health and wellbeing
of the community and its members, for instance, with regard to diet or a hazardous occupation.
Epidemiological studies may inadvertently expose groups to harm. When the location or specific
circumstances of a study are important to understanding the results, care should be taken to
protect the confidentiality of respondents and the community itself.
A more serious problem may emerge when telling the truth and openly disclosing scientific
findings are opposed by certain community leaders or interest groups, or could lead to economic
loss or withdrawal of health and other services. This may depend on how the data is presented and
interpreted, that is, the style and tone of the report or publication should avoid adverse or moral
criticism and be discrete in communicating and explaining the findings. Weijer and Emanuel
(2000) suggested that if agreement between researchers and the community representatives cannot
be attained within a reasonable amount of time, the competing interpretations of the study should
both be published.
CONCLUSION
Scientific journals have been assigned an after the fact policing role in the enforcement of
human research protections. This is a form of self-censorship and suppression of scientific
knowledge which reflects social, political, and cultural pressures on what is studied, how studies
are performed, how data are interpreted, and how results are disseminated (Kempner, Perlis, Merz,
2005). This can include refusing to publish material that might be detrimental to national security
or studies that obtained data through unacceptable means, such as experiments that harm humans.
Public health journals face a challenge in supporting human research protections. The
journals clearly need to distinguish between research and non-research or practice articles.
Weijer (1999) thought that a reasonable formulation of the principle of respect for communities
conferred on the researcher an obligation to respect the values and interests of the community in
research and, wherever possible, to protect the community from harm. By extension, this
suggests that public health journals should develop a set of guidelines for publication that
encompass respect for communities.
Institutional Review Boards (IRBs) do not routinely consider the benefits and risks to
communities or populations. Further IRBs may not recognize that the collection of data for
surveillance, disease control and prevention, and program development and evaluation may be
legally mandated, covered by the HIPAA privacy rule, or be eligible for a waiver or qualify as
exempt from informed consent. Public health journals should not require that all authors obtain
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IRB approval in order to be published since some articles concern practice not research. The
journals, however, should require documentation that funding agencies or data sources have
released the data or made it public, and that the data collecting process observed the HIPAA
Privacy Rules in obtaining the information for publication.
Journals should be more proactive through editorial policies. Journals should alert
reviewers to the possibility, however remote, that data can be falsified and to check that the work
has proper and sufficient references and citations to avoid charges of plagiarism. Editors should
ensure that the tone of the article is respectful and not inflammatory or prejudicial. Many journals
and government publications will not identify smaller governmental subdivisions and will not
publish data in a cell that contains less than 50 respondents or subjects, especially if they are
members of a minority group or vulnerable population. In case studies and program evaluations,
journals should not publish names or otherwise link an individual to a specific data item and
should carefully consider whether a community should be identified or a pseudonym used.
Of course the editor, editorial board, and peer reviewers can and should decide which
section of the journal they think is appropriate for a manuscript. Certainly peer review and
publication involves many of the same questions that IRBs ask: what were the methods used to
recruit or select subjects, were reliable and valid scientific methods used, was the data collected
in a way that protected privacy, does the manuscript protect the identities of individual subjects
and communities when appropriate. But journals should maintain their independence, meaning
they should not rely solely on IRB decisions or automatically enforce them after the fact.
Harry Perlstadt, Ph.D. M.P.H. is a Professor of Sociology and Director of the Program in
Bioethics, Humanities and Society at Michigan State University.
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